Clinical Trial Update: SSRI Effects on Depression and Immunity in HIV/AIDS [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating SSRIs' effects on depression and immune markers in people with HIV/AIDS. Results were posted in May 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Major Depressive Disorder

Snippet

Sponsor: University of Pennsylvania | Conditions: Depression, HIV | Phase 4 | Status: COMPLETED | Results posted: 2024-05-07